BLEOMYCIN
Generic: BLEOMYCIN SULFATE
Fresenius Kabi USAManufacturer
INTRAMUSCULAR, INTRAPLEURAL, INTRAVENOUS, SUBCUTANEOUSRoute
BLEOMYCIN SULFATEActive Substance
2008-01-28Original Approval
BLEOMYCIN is FDA application ANDA065185, sponsored by FRESENIUS KABI USA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class I2023-12-21
Bleomycin for Injection, USP, 15 units per vial, 1 single dose glass fliptop vial, Rx Only, Distributed by: Hospira, IncPresence of particulate matter: glass
Class III2021-08-05
Bleomycin for Injection, USP, packaged in 15 units per single dose vial, Rx only, Manufactured by Thymoorgan Pharmazie GLabeling: Not elsewhere classified: Mislabeling
Top Reported Reactions
1
FEBRILE NEUTROPENIA
828 reports
2
OFF LABEL USE
803 reports
3
NEUTROPENIA
605 reports
4
DRUG INEFFECTIVE
510 reports
5
PYREXIA
467 reports
6
PULMONARY TOXICITY
417 reports
7
VOMITING
379 reports
8
NAUSEA
370 reports
9
ANAEMIA
360 reports
10
THROMBOCYTOPENIA
356 reports